Communiqués Nightingale Health Oyj

Actions

HEALTH

FI4000490875

Marché Fermé - Nasdaq Helsinki Autres places de cotation 18:00:00 27/06/2024			Varia. 5j.	Varia. 1 janv.
1,825 ^EUR	+8,63%		+6,73%	+63,53%

27/06	Nightingale Health sécurise les actifs de propriété intellectuelle du dispositif de prélèvement sanguin Velvet	MT
16/04	Nightingale Health ouvre un laboratoire aux États-Unis	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Nightingale Health and ZOE expand research collaboration to include self-collected blood samples	27/06	AQ
Nightingale Health acquires all intellectual property assets of the Velvet™ blood collection device and secures its position as the sole provider of a fully integrated remote health check solution	27/06	AQ
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Cor Group Oy)	18/06	AQ
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Pasi Soininen)	18/06	AQ
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Teemu Suna)	18/06	AQ
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Antti Kangas)	18/06	AQ
Conversion of Nightingale Health Plc's Series A shares to Series B shares	11/06	AQ
Health check based on advanced blood analysis technology builds a better foundation for public health	06/06	AQ
Nightingale Health's Board of Directors extended the subscription period of employee option rights	23/05	AQ
Nightingale Health launches new website aligned with the B2B and B2G strategy	21/05	AQ
Inside information: Nightingale Health achieves one of its business targets for this financial year by winning contracts in medical research with a total contract value of at least EUR 3.2 million	25/04	AQ
Nightingale Health to establish a laboratory in the United States with Weill Cornell Medicine as the first customer	16/04	AQ
Supplement to the release: Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.	12/04	AQ
Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.	12/04	AQ
Nightingale Health has completed the acquisition of Welltus Inc	29/03	AQ
Conversion of Nightingale Health Plc's EMP shares to Series B shares	20/03	AQ
Nightingale Health's technology used to analyze Uganda's General Population Cohort (GPC)	19/03	AQ
Supplement to the release: Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc	07/03	AQ
Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc	07/03	AQ
Nightingale Health's Half-year report: Healthcare implementations progressing in Finland and Singapore	07/03	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Nightingale Health Oyj

Actions

HEALTH

FI4000490875

Communiqués

Filtres